International Conference on Efficacy and Safety in Immunotherapy

Efficacy and Safety in Immunotherapy Conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Efficacy and Safety in Immunotherapy Conference. It also provides a premier interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Efficacy and Safety in Immunotherapy Conference.

Upcoming Conferences

DIGITAL
London
June 2022 in London
  • Conference Code: 22GB06ICESI002
  • Abstract/Full-Text Paper Submission: May 17, 2022
  • Notification of Acceptance/Rejection: May 31, 2022
  • Final Paper and Early Bird Registration: May 27, 2022
  • Conference Date: June 27-28, 2022
Amsterdam
January 2023 in Amsterdam
  • Conference Code: 23NL01ICESI002
  • Abstract/Full-Text Paper Submission: May 17, 2022
  • Notification of Acceptance/Rejection: May 31, 2022
  • Final Paper and Early Bird Registration: December 15, 2022
  • Conference Date: January 21-22, 2023
London
June 2023 in London
  • Conference Code: 23UK06ICESI002
  • Abstract/Full-Text Paper Submission: July 01, 2022
  • Notification of Acceptance/Rejection: August 01, 2022
  • Final Paper and Early Bird Registration: May 27, 2023
  • Conference Date: June 28-29, 2023
Amsterdam
January 2024 in Amsterdam
  • Conference Code: 24NL01ICESI002
  • Abstract/Full-Text Paper Submission: August 01, 2023
  • Notification of Acceptance/Rejection: September 04, 2023
  • Final Paper and Early Bird Registration: December 15, 2023
  • Conference Date: January 21-22, 2024
London
June 2024 in London
  • Conference Code: 24UK06ICESI002
  • Abstract/Full-Text Paper Submission: August 01, 2023
  • Notification of Acceptance/Rejection: September 04, 2023
  • Final Paper and Early Bird Registration: May 27, 2024
  • Conference Date: June 28-29, 2024